Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Vitamin D supplementation was linked to a significantly greater reduction in total PMS scores contrasted to the control group (n = 3 RCTs; SMD: −0.78; 95% CI [−1.30, −0.26]; p < 0.001; I2 = 58.22%) (Figure 3A).
Source: 3.4. Primary Outcome: PMS Total Score. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Efficacy of Vitamin D Supplementation to Alleviate Premenstrual Syndrome Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Source: Article title.
Efficacy of Vitamin D Supplementation to Alleviate Premenstrual Syndrome Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Efficacy of Vitamin D Supplementation to Alleviate Premenstrual Syndrome Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Systematic review · Journal of Clinical Medicine · 2026
Original publication title
Efficacy of Vitamin D Supplementation to Alleviate Premenstrual Syndrome Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
© 2026 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Premenstrual Syndrome (PMS) substantially impairs quality of life, while standard pharmacologic treatments are often limited by adverse effects or contraindications. This systematic review and meta-analysis evaluated the efficacy of vitamin D supplementation compared to passive control (placebo or standard care) for PMS symptom relief.
Source: AimAbstract: Results
Five RCTs including 436 participants were reviewed. The overall risk of bias was rated as “some concerns” in four RCTs and “low risk” in one trial. Vitamin D significantly reduced total PMS severity (SMD: −0.78, 95% CI: −1.30, −0.26, I2 = 58.22%) as well as physical symptoms (SMD: −1.00, 95% CI: −1.99, −0.01, I2 = 90.53%) and depression (SMD: −0.78, 95% CI: −1.53, −0.02, I2 = 84.56%). No significant effects were observed for anxiety, craving, or water retention. Vitamin D was well tolerated with no reported adverse events.
Source: ResultsAbstract: Conclusions
Vitamin D supplementation may reduce overall PMS severity, particularly physical and depressive symptoms. However, results show substantial heterogeneity across outcomes, and the certainty of evidence remains “very low”, underscoring the need for further high-quality, well-powered RCTs.
Source: ConclusionsAuthors’ abstract
Aim:
Premenstrual Syndrome (PMS) substantially impairs quality of life, while standard pharmacologic treatments are often limited by adverse effects or contraindications. This systematic review and meta-analysis evaluated the efficacy of vitamin D supplementation compared to passive control (placebo or standard care) for PMS symptom relief.
Methods:
PubMed, Web of Science, Scopus, Google Scholar, and CENTRAL were searched for randomized controlled trials (RCTs) up to January 2026. The primary outcome was change in total PMS severity scores. Secondary outcomes included depression, anxiety, physical symptoms, craving, and water retention. Standardized mean differences (SMDs) with 95% confidence intervals (CI) were pooled using a random-effects model. Heterogeneity was assessed using the I2 statistic.
Results:
Five RCTs including 436 participants were reviewed. The overall risk of bias was rated as “some concerns” in four RCTs and “low risk” in one trial. Vitamin D significantly reduced total PMS severity (SMD: −0.78, 95% CI: −1.30, −0.26, I2 = 58.22%) as well as physical symptoms (SMD: −1.00, 95% CI: −1.99, −0.01, I2 = 90.53%) and depression (SMD: −0.78, 95% CI: −1.53, −0.02, I2 = 84.56%). No significant effects were observed for anxiety, craving, or water retention. Vitamin D was well tolerated with no reported adverse events.
Conclusions:
Vitamin D supplementation may reduce overall PMS severity, particularly physical and depressive symptoms. However, results show substantial heterogeneity across outcomes, and the certainty of evidence remains “very low”, underscoring the need for further high-quality, well-powered RCTs.
Publication and source details
Original title: Efficacy of Vitamin D Supplementation to Alleviate Premenstrual Syndrome Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Amani Zainab; Reem Samir Tageldin; Rumaysah Patel; Mohamed Abdulrahim Hassan; Lama Atef Aburas; Marya Alkahily; Layan Shamsan; Salma Salman Al-Olaimat; Ashaz Sayeed; Ahmed Abu-Zaid
Journal of Clinical Medicine · 2026
* Correspondence: amabuzaid@alfaisal.edu© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-09T20:25:16.786880+00:00
DOI: 10.3390/jcm15124828 · PMC13301900